CASE REPORTS

Relapse of visceral leishmaniasis in a cured case after 64 years

  • ZHANG Ai-ping ,
  • LIANG Man-man ,
  • ZHU Ling-ling ,
  • SHENG Hao-yu ,
  • YANG Jiang-hua
Expand
  • Department of Infectious Diseases, Yijishan Hospital, Wannan Medical College, Wuhu 241001, China

Received date: 2021-07-30

  Revised date: 2021-11-17

  Online published: 2022-03-11

Abstract

A 74-year-old patient from Juxian County, Rizhao, Shandong Province was diagnosed with visceral leishmaniasis and treated with pentavalent antimony for 6 d in the local hospital of Juxian in 1957. In 1964, the patient migrated to Ma’anshan City, Anhui Province. In October 2014, He travelled back to Juxian County for two weeks before returning to Ma’anshan City. In July 2020, he migrated to Bozhou City, Anhui Province. The patient denied any history of being bitten by sandfly, living with a dog at home during this period. The patient had no contact history of visceral leishmaniasis patients or Leishmannia infected dogs. The patient presented unexplained emaciation and fatigue from July 2020, and dizziness from April 2021. The patient had a sudden high fever without obvious inducement and aggravated fatigue and dizziness in June 2021. Bone marrow smear examination revealed Leishmania parasite flagellate body. The metagenomic analysis of the bone marrow pathogenic microorganisms revealed 30 366 sequences of the Leishmania genus, including 128 sequences of Leishmania donovani. Serum rk39 immunochromatographic strip showed a positive result. Combining the epidemiological history and labortory test results, a recurrent visceral leishmaniasis diagnosis was made. The patient was discharged after treatment with pentavalent antimony (0.6 g/d, intramuscular injection, 6 g, one course of 10 days). The patient was followed up by telephone after discharge, and showed no fever but did not go to the hospital for review.

Cite this article

ZHANG Ai-ping , LIANG Man-man , ZHU Ling-ling , SHENG Hao-yu , YANG Jiang-hua . Relapse of visceral leishmaniasis in a cured case after 64 years[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022 , 40(2) : 266 -268 . DOI: 10.12140/j.issn.1000-7423.2022.02.022

References

[1] Chen XY,, Yang LY,, Zhao Y, et al. A study of the clinical application values of bone marrow examination and rK39 test strip in patients with sufferer performance[J]. Labeled Immunoass Clin Med, 2017, 24(11): 1252-1253, 1268. (in Chinese)
[1] (陈曦阳,, 杨柳莹,, 赵仪, 等. 探讨骨髓检查和rK39试纸条方法对临床黑热病表现症患者检测效果[J]. 标记免疫分析与临床, 2017, 24(11): 1252-1253, 1268.)
[2] Editorial Board of the Chinese Journal of Infectious Diseases. Expert consensus on diagnosis and treatment of Leishmania infection in China[J]. Chin J Infect Dis, 2017, 35(9): 513-518. (in Chinese)
[2] (《中华传染病杂志》编辑委员会. 中国利什曼原虫感染诊断和治疗专家共识[J]. 中华传染病杂志, 2017, 35(9): 513-518.)
[3] Mondal D,, Alvar J,, Hasnain MG, et al. Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study[J]. Lancet Glob Health, 2014, 2(1): e51-e57.
[4] Alvar J,, Vélez ID,, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence[J]. PLoS One, 2012, 7(5): e35671.
[5] Zhang P,, Shen ZY,, Zhang YP, et al. Research progress of clinical epidemiology, prevention and treatment on visceral leishmaniasis[J]. Med J Natl Defending Forces Northwest China, 2019, 40(11): 703-708. (in Chinese)
[5] (张鹏,, 沈兆媛,, 张亚萍, 等. 我国内脏利什曼病临床流行病学特征与防治研究现状[J]. 西北国防医学杂志, 2019, 40(11): 703-708.)
[6] Liao ZW,, Wang SQ. Prevalence and prevention of major tropical diseases in China, 2000-2019[J]. Chin Trop Med, 2020, 20(3): 193-201. (in Chinese)
[6] (廖志武,, 王善青. 我国2000-2019年主要热带病的流行与防治概况[J]. 中国热带医学, 2020, 20(3): 193-201.)
[7] Zhao RR,, Li M,, Deng YD, et al. Epidemiology and clinical characteristics of 46 patients with visceral leishmaniasis[J]. Chin J Infect Dis, 2018, 36(6): 366-369. (in Chinese)
[7] (赵荣荣,, 李敏,, 邓永东, 等. 内脏利什曼病患者46例流行病学及临床特征分析[J]. 中华传染病杂志, 2018, 36(6): 366-369.)
[8] Zhang LP,, Zhang FN. Epidemiological and clinical analysis of 166 kala-azar cases[J]. Parasitoses Infect Dis, 2010, 8(4): 181-186. (in Chinese)
[8] (张丽萍,, 张富南. 黑热病166例病例流行病学与临床分析[J]. 寄生虫病与感染性疾病, 2010, 8(4): 181-186.)
[9] Wang JY,, Gao CH. Interpretation of diagnostic criteria for kala-azar[J]. Chin J Schisto Control, 2017, 29(5): 541-543. (in Chinese)
[9] (汪俊云,, 高春花. 《黑热病诊断标准》解读[J]. 中国血吸虫病防治杂志, 2017, 29(5): 541-543.)
[10] Xu NN,, Zhou M,, Yin M, et al. The value of high-throughput sequencing in the pathogenic detection of sepsis[J]. Chin J Crit Care Intensive Care Med Electron Ed, 2019, 5(2): 199-202. (in Chinese)
[10] 许娜娜,, 周敏,, 尹梅, 等. 高通量测序技术在脓毒症病原微生物检测中的价值[J]. 中华重症医学电子杂志(网络版), 2019, 5(2): 199-202.)
[11] Wang ZJ. Kala-azar[M]// Hou KJ. Historical experience of preventive medicine in Shandong Province. Jinan: Shandong Science and Technology Press, 1987: 435-436. (in Chinese)
[11] (王兆俊. 黑热病[M]//侯克济. 山东省预防医学历史经验. 济南: 山东科学技术出版社, 1987: 435-436.)
[12] Wang ZJ. Main achievements in the control of kala-azar in Shandong Province[J]. Shandong Med J, 1959(10): 8-13. (in Chinese)
[12] (王兆俊. 山东省黑热病防治研究上的主要成就[J]. 山东医刊, 1959(10): 8-13.)
[13] Wang ZJ,, Wu ZJ,, He KZ. Research progress of kala-azar control in China since 1960[J]. J Parasitol Parasit Dis, 1983, 1(2): 65-72. (in Chinese)
[13] (王兆俊,, 吴征鉴,, 何凯增. 1960年来我国黑热病防治研究工作进展[J]. 寄生虫学与寄生虫病杂志, 1983, 1(2): 65-72.)
[14] Xiong GH. Kala-azar in China from 1985-1988[J]. Chin J Parasitol Parasit Dis, 1989, 7(3): 161-162. (in Chinese)
[14] (熊光华. 1985-1988年全国黑热病疫情动态[J]. 中国寄生虫学与寄生虫病杂志, 1989, 7(3): 161-162.)
[15] Wang ZJ,, Bao Y,, Shao QF, et al. Immunological evaluation of kala-azar control measures in Shandong Province[J]. Chin J Parasit Dis Control, 1991, 4(2): 81-85. (in Chinese)
[15] (王兆俊,, 鲍勇,, 邵其峰, 等. 山东省黑热病防治效果的免疫学评价与有关问题的探讨[J]. 中国寄生虫病防治杂志, 1991, 4(2): 81-85.)
[16] Wan GQ,, Liu X,, Miao F, et al. Surveillance on sand-fly after kala-azar was eliminated in Shandong Province[J]. Chin J Parasit Dis Control, 2003, 16(4): 244. (in Chinese)
[16] (万功群,, 刘新,, 缪峰, 等. 山东省消除黑热病后的白蛉监测[J]. 中国寄生虫病防治杂志, 2003, 16(4): 244.)
[17] Zhou ZB,, Li YY,, Zhang Y, et al. Analysis of national visceral leishmaniasis epidemic in 2018[J]. Chin J Parasitol Parasit Dis, 2020, 38(2): 175-180, 187. (in Chinese)
[17] (周正斌,, 李元元,, 张仪, 等. 2018年全国内脏利什曼病疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(2): 175-180, 187.)
[18] Zhang ZG. A case report of kala-azar relapse 26 years later[J]. Chin J Parasitol Parasitol Dis, 1990, 8(4): 287. (in Chinese)
[18] (张志恭. 26年后黑热病复发一例报告[J]. 中国寄生虫学与寄生虫病杂志, 1990, 8(4): 287.)
[19] Zhang FN,, Zhang LP. Analysis on recurrence and death of leishmaniasis cases in Sichuan Province[J]. J Prev Med Inf, 2010, 26(12): 961-965. (in Chinese)
[19] (张富南,, 张丽萍. 四川省黑热病复发和死亡原因分析[J]. 预防医学情报杂志, 2010, 26(12): 961-965.)
[20] Xie XQ,, Jiang L,, He L, et al. Analysis of the recurrence of kala-azar in 208 children[J]. J Clin Pediatr, 1996, 14(4): 237-238. (in Chinese)
[20] (谢孝泉,, 江霖,, 何莉, 等. 小儿黑热病208例复发原因及疗效分析[J]. 临床儿科杂志, 1996, 14(4): 237-238.)
Outlines

/

〈 〉